Astec LifeSciences Limited reported unaudited standalone and consolidated earnings results for the first quarter ended June 30, 2018. For the quarter, on standalone basis, the company reported revenue from operations of INR 654.728 million compared to INR 722.705 million a year ago. Total income was INR 654.908 million compared to INR 752.241 million a year ago. Profit before exceptional items and tax was INR 24.329 million compared to INR 59.656 million a year ago. Profit before tax was INR 24.329 million compared to INR 59.656 million a year ago. Net profit for the period was INR 14.769 million or INR 0.08 per diluted share compared to INR 39.891 million or INR 2.04 per diluted share a year ago. For the quarter, on consolidated basis, the company reported revenue from operations of INR 654.728 million compared to INR 722.705 million a year ago. Total income was INR 654.908 million compared to INR 752.241 million a year ago. Profit before exceptional items and tax was INR 24.479 million compared to INR 59.708 million a year ago. Profit before tax was INR 24.479 million compared to INR 59.708 million a year ago. Net profit for the period was INR 14.855 million or INR 0.08 per diluted share compared to INR 39.869 million or INR 2.04 per diluted share a year ago.